相关实验视频

Updated: Jun 22, 2025

Evaluating In Vitro DNA Damage Using Comet Assay

Evaluating In Vitro DNA Damage Using Comet Assay

Published on: October 11, 2017

伊洛佩里和特莫索洛米德协同抑制了 Glioblastoma 细胞的生长,迁移和增强细胞亡

Sahar Mubeen¹, Iffat Raza², Badaruddin Ujjan³

¹Department of Anatomy, Dow International Medical College, Dow University of Health Sciences, Karachi 75330, Pakistan.

|June 27, 2024

概括

非典型的抗精神病药物伊洛佩里 (ILO) 显示出对质母细胞瘤 (GBM) 的治疗潜力. 与Temozolomide (TMZ) 结合,ILO协同抑制了GBM细胞的生长,迁移和入侵,提供了一个有前途的药物重新定位策略.

科学领域:

神经瘤学神经瘤学
药理学药理学是指药理学的学科.
药物重用药物重用

背景情况:

质母细胞瘤 (GBM) 是一种具有侵略性的脑瘤,治疗选择有限,预后不佳.
流行病学数据表明,抗精神病药物的使用与减少GBM发病率之间存在潜在联系.
药物重定向提供了一种具有成本效益的策略,以确定新的GBM治疗方法.

研究的目的:

调查非典型抗精神病药物伊洛佩里 (ILO) 对抗GBM的治疗潜力.
在GBM细胞系中评估ILO单独和与Temozolomide (TMZ) 结合的疗效.
探索国际劳工组织反GBM活动背后的分子机制.

主要方法:

使用MTT测试来评估细胞活力和生长抑制.
迁移,入侵和TUNNEL测试评估了细胞行为和细胞亡.
使用RTq-PCR和免疫细胞化学分析基因和蛋白质表达 (DRD2,β-catenin,Dvl2,Twist,Slug).

主要成果:

伊洛佩里 (ILO) 和特莫佐洛米德 (TMZ) 显著抑制了GBM细胞的生长.
国际劳工组织和TMZ的组合表明了协同作用 (CDI < 1).
组合治疗显著增强了细胞亡,并抑制了细胞迁移和侵入.
国际劳工组织和组合治疗降低了DRD2,而TMZ则提高了DRD2;所有治疗都降低了β-catenin,Dvl2,Twist和Slug.

结论:

伊洛佩里具有显著的抗GBM活性,影响细胞生长,迁移和入侵.
国际劳工组织和TMZ的协同效应表明,对于GBM来说,这是一个有前途的组合疗法.
伊洛佩里的治疗潜力可以通过调节DRD2和β-catenin通路来调节.

关键词:

伊洛佩里多尼 (Iloperidone) 是一种非典型的抗精神病药物.质母细胞瘤是一种质母细胞瘤.泰莫索洛米德 (temozolomide) 是一种有毒的物质.

更多相关视频

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...